LASIK offers good long-term results for high myopes

Article

LASIK for myopia over -10 D is both safe and effective in the long-term.

LASIK for myopia over -10 D is both safe and effective in the long-term, according to a report published in the January issue of the American Journal of Ophthalmology.

Jorge Alio of the Miguel Hernandez University Medical School, Alicante, and of the VISSUM, Instituto Oftalmologico de Alicante, Spain and colleagues from Ankara University of Medicine, Turkey enrolled 196 highly myopic eyes of 118 patients who, preoperatively, required at least 10 D corrections in order to achieve 20/20 vision. All patients were available to follow-up 10 years after initial surgery.

Prior to surgery, uncorrected vision was 77% of best corrected visual acuity (BCVA). Just 5% of eyes lost more than 2 lines BCVA, 40% were able to avoid wearing spectacles and 61% were within ±2 D at 10 years. Only two eyes (1%) developed corneal ectasia.

This study demonstrates that LASIK can offer excellent results in terms of predictability, efficacy and safety for highly myopic patients over the long-term.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.